ConductScience.org, home

Trial · NCT02896127

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
COMPLETED WEEK 52STARTEDSecukinumab305
COMPLETED WEEK 52STARTEDPlacebo153
COMPLETED WEEK 52COMPLETEDSecukinumab278
COMPLETED WEEK 52COMPLETEDPlacebo142
COMPLETED WEEK 52NOT COMPLETEDSecukinumab27
COMPLETED WEEK 52NOT COMPLETEDPlacebo11
COMPLETED POST-TREATMENT FOLLOW UPSTARTEDSecukinumab280
COMPLETED POST-TREATMENT FOLLOW UPSTARTEDPlacebo139
COMPLETED POST-TREATMENT FOLLOW UPCOMPLETEDSecukinumab276
COMPLETED POST-TREATMENT FOLLOW UPCOMPLETEDPlacebo134
COMPLETED POST-TREATMENT FOLLOW UPNOT COMPLETEDSecukinumab4
COMPLETED POST-TREATMENT FOLLOW UPNOT COMPLETEDPlacebo5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02896127/flow